2018
DOI: 10.2147/cia.s146871
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly

Abstract: ObjectiveWe studied the efficacy of zoledronic acid (ZOL) infusion on radiographic and clinical outcomes after percutaneous kyphoplasty (PKP) for elderly patients with osteoporotic thoracolumbar fractures (osteoporotic vertebral compression fractures [OVCFs]).Materials and methodsWe retrospectively analyzed 95 elderly patients (age >65 years) with OVCF. All patients were followed up for 2 years. Thirty-two patients were treated with only once-yearly 5 mg ZOL infusion (ZOL group), 34 patients with only PKP (PKP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 31 publications
0
13
0
Order By: Relevance
“…Besides, no sufficient diagnosis of osteoporosis was performed and no anti-osteoporotic therapy was started in the majority of the patients despite the clear recommendation for it in the discharge report. The low number of patients who received sufficient antiosteoporotic therapy might be partially responsible for the high rate of sequential vertebral fractures and might negatively affect clinical outcomes [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…Besides, no sufficient diagnosis of osteoporosis was performed and no anti-osteoporotic therapy was started in the majority of the patients despite the clear recommendation for it in the discharge report. The low number of patients who received sufficient antiosteoporotic therapy might be partially responsible for the high rate of sequential vertebral fractures and might negatively affect clinical outcomes [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…advised for treating OTFs in clinical routine practice, and we are unable to determine whether PV causes new symptomatic vertebral fractures and/or serious adverse events as well as an increased risk of PV in acute OTFs [9][10][11][12] . There are no severe complications due to treatment, and although PMMA leakage frequently occurs, it is always asymptomatic [13][14][15] .…”
Section: Discussionmentioning
confidence: 99%
“…Besides, no su cient diagnosis of osteoporosis was performed and no anti-osteoporotic therapy was started in the majority of the patients despite the clear recommendation for it in the discharge report. The low number of patients who received su cient antiosteoporotic therapy might be partially responsible for the high rate of sequential vertebral fractures and might negatively affect clinical outcomes [43].…”
Section: Discussionmentioning
confidence: 99%